Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

The randomized, controlled PALISADE trial demonstrated the benefit of daily oral immunotherapy with Peanut (Arachis Hypogaea) allergen powder-dnfp (PTAH, formerly AR101) in peanut-allergic children and adolescents.ARC004, the open-label follow-on study to PALISADE, used 5 dosing cohorts to explore P...

Descripció completa

Guardat en:

Dades bibliogràfiques
Autors principals:	Brian P. Vickery, Andrea Vereda, Caroline Nilsson, George Du Toit, Wayne G. Shreffler, A. Wesley Burks, Stacie M. Jones, Montserrat Fernández‐Rivas, Katharina Blümchen, Jonathan O’B Hourihane, Kirsten Beyer, Aikaterini Anagnostou, Amal Assa’ad, Moshe Ben‐Shoshan, J. Andrew Bird, Tara F. Carr, Warner Carr, Thomas B. Casale, Hey Chong, Christina E. Ciaccio, Morna J. Dorsey, Stanley M. Fìneman, Stephen B. Fritz, Alexander N. Greiner, Leon S. Greos, Frank C. Hampel, María Ibáñez-Vea, David Jeong, Douglas Johnston, Rita Kachru, Edwin Kim, Bruce J. Lanser, Stephanie A. Leonard, Mary C. Maier, Lyndon E. Mansfield, Antonella Muraro, Jason Ohayon, J. N. G. Oude Elberink, Daniel Petroni, Jacqueline A. Pongracic, Jay M. Portnoy, Rima Rachid, Ned T. Rupp, Georgiana Sanders, Hemant Sharma, Vibha Sharma, Ellen Sher, Lawrence Sher, Sayantani Sindher, Dareen Siri, Jonathan M. Spergel, A. B. Sprikkelman, Gordon L. Sussman, Marina Tsoumani, Pooja Varshney, Girish Vitalpur, Julie Wang, William H. Yang, José Manuel Zubeldia, Alex Smith, Robert Ryan, Daniel C. Adelman
Format:	Artigo
Idioma:	anglès
Publicat:	2020
Accés en línia:	https://doi.org/10.1016/j.jaip.2020.12.029 http://www.jaci-inpractice.org/article/S2213219820313611/pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Sigues el primer a deixar un comentari!

Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

Ítems similars